Author's posts
NIH advisers urge tighter oversight of experiments on deadly viruses
Debate over pathogen research has grown more rancorous amid speculation that some kind of “lab leak” might have played a role in the origin of the coronavirus.
Covid forecast: Major fall surge unlikely, but variants are a wild card
Infectious disease experts are guardedly optimistic that the reformulated covid boosters and built-up immunity will prevent a fall covid surge.
Scientists hone argument that coronavirus came from Wuhan market
The coronavirus pandemic began in separate viral spillovers from live animals sold and butchered in late 2019 in a Wuhan, China, seafood market, according to two papers published Tuesday in the journal Science.
President Biden, double-boosted, is in a good position to fight covid
President Biden, who tested positive for the coronavirus Thursday, has been fully vaccinated and twice-boosted, as recommended for people his age, and has an excellent chance of avoiding the most severe outcomes from covid, according to doctors intervi…
As the BA.5 variant spreads, the risk of coronavirus reinfection grows
The latest omicron offshoot, BA.5, has quickly become dominant in the United States, driving a wave of reinfections across the country.
Virus mutations aren’t slowing down. New omicron subvariant proves it.
More than two years after it first spilled into humans, the virus continues to change its structure and chemistry in ways that confound efforts to bring it fully under control.
Boost now? Boost later? Tricky calculation for a 4th coronavirus shot.
Uncertainty about a fourth shot reflects the confusion about boosters that has dogged the government’s vaccination campaign.
U.S. life expectancy continued to drop in 2021, new analysis shows
In 2020, a dramatic decline in life expectancy was most pronounced among Hispanic and Black Americans, a reflection of the disproportionate impact of the coronavirus. But in 2021, Whites drove the entirety of the decline.
Latest version of omicron accounts for most new infections in many parts of the U.S., genomics testing shows
The estimate comes amid concerns that Europe’s BA.2-driven surge in infections will be replicated in coming weeks in the United States.
NIH orders sweeping review of potentially risky experiments on viruses and other pathogens
The National Institutes of Health hopes to have recommendations by the end of the year.
